Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Balgrist University Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
Pain is a public health challenge around the world. However, there is no single standardized measure of pain, to the point that the estimated prevalence of chronic pain in adults ranges between 2% and 64% depending on the methods and definitions used. Existing measures of pain are known to present several problems and results can be hardly compared between people.
The investigators propose and empirically validate a new, simple method to measure experienced pain in clinical trials. The method provides an objective, cardinal measurement of experienced pain which is comparable between people and the investigators test whether it is better able to measure experienced pain than existing procedures. The investigators test the new method in healthy participants using standard protocols (electrical and heat stimuli). The investigators also aim to validate the measure using a causal manipulation which relies on the administration of a topical analgesic product compared to a placebo.
The aim of this study is to establish and validate the proposed method of measuring pain using different pain stimuli. The investigators correlate these measurements with physiological data such as skin-conductance, heart-rate variability, pupil dilation, and with established measures of pain such as Numeric rating scale (NRS), Visual analog scale (VAS), general Labeled Magnitude Scale (gLMS). In addition, the investigators study the test-retest reliability of our measure of pain and its ability to capture a reduction in experienced pain due to a topical analgesic product compared to a placebo treatment.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Study 1 Low-Intensity Group | Active Comparator | Control group which receives less intense electrical stimuli than the other. |
|
| Study 1 High-Intensity Group | Experimental | Group which receives more intense electrical stimuli than the other. |
|
| Study 2 Low-Intensity Group | Active Comparator | Control group which receives less intense heat stimuli than the other. |
|
| Study 2 High-Intensity Group | Experimental | Group which receives more intense heat stimuli than the other. |
|
| Study 3 Placebo group | Placebo Comparator | A group that receives a placebo cream. |
|
| Study 3 Painkiller group |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Developing an objective measure of experienced pain | Behavioral | At the beginning of each study, participants are randomly allocated into one of two groups. Within each group all participants are exposed to the same painful stimulus. One group experiences a painful stimulus of higher intensity compared to that of the other group. The painful stimuli are physically identical for every subject within the same group and within the standard of previous pain research. Participants are then asked to evaluate the painful stimulus they just received according to a self-reported scale (NRS, VAS, gLMS, NRS-MB). Participants are also asked to decide multiple times whether they prefer a larger amount of money and experience the same or more painful stimulus they received before or a smaller amount of money and no (or a less) painful stimulus. The smaller amount of money is progressively increased across choices until it matches the larger amount, similar to multiple price-list methods (MPL) which are standard in economics. |
| Measure | Description | Time Frame |
|---|---|---|
| Choices between monetary amounts and painful stimuli | Participants' choices between monetary amounts and painful stimuli | baseline |
| self-reported pain ratings according to Numerical Rating Scale (NRS) | self-reported pain ratings according to Numerical Rating Scale | baseline |
| self-reported pain ratings according to Visual Analogue Scale (VAS) | self-reported pain ratings according to Visual Analogue Scale | baseline |
| self-reported pain ratings according to general Labeled Magnitude Scale (gLMS) | self-reported pain ratings according to general Labeled Magnitude Scale | baseline |
| response times | Response times relative to participants' choices between monetary amounts and painful stimuli | baseline |
| Measure | Description | Time Frame |
|---|---|---|
| heart rate variability | variation in heat-beat rate in reaction to the painful stimuli. | baseline |
| skin conductance | variation in skin conductance in reaction to the painful stimuli. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| SNS Laboratory | Zurich | CH | 8091 | Switzerland |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D059787 | Acute Pain |
| D010146 | Pain |
| ID | Term |
|---|---|
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Experimental |
A group that receives a topical analgesic such as EMLA cream. |
|
| Study 4 test-retest reliability group | No Intervention | Participants who participated in either Study 1 or 2 are recruited. They will experience both electrical and heat stimuli. |
|
| baseline |
| pupil dilation | variation in pupil dilation in reaction to the painful stimuli. | baseline |